The VeriSeq™ NIPT Solution

2018年5月17日

It’s time to rethink NIPT. Introducing the VeriSeq NIPT solution, a powerful screening test from Illumina that can provide information on the health of a developing fetus using a simple maternal blood draw. Watch how one tube of blood is processed into uniquely tagged cfDNA libraries. See how cfDNA libraries are sequenced as paired reads, and discover how paired reads generate confident calls—all in one user-friendly process. For In Vitro Diagnostic Use. Not available in all countries and regions. QB 5701 Subscribe to the Illumina video channel http://www.youtube.com/subscription_center?add_user=IlluminaInc A global genomics leader, Illumina provides comprehensive next-generation sequencing solutions to the research, clinical, and applied markets. Illumina technology is responsible for generating more than 90% of the world’s sequencing data.* Through collaborative innovation, Illumina is fueling groundbreaking advancements in oncology, reproductive health, genetic disease, microbiology, agriculture, forensic science, and beyond. *Data calculations on file. Illumina, Inc., 2017.

View customer spotlight videos 

View Illumina webinars 

View Illumina product videos 

View Illumina support videos 

この記事を共有します